Iron Overload: Pathophysiology, Diagnosis and Monitoring.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing pathophysiology, diagnosis, and monitoring without primary human data or systematic search methodology.
PubMed 42083434 · doi:10.1111/ijlh.70132
What was done
This narrative review synthesized the pathophysiological mechanisms, diagnostic pathways, and monitoring strategies for chronic primary iron overload (hereditary hemochromatosis) and secondary iron overload (thalassemia, sickle cell disease, and myelodysplastic syndromes).
What was found
The abstract reports no quantitative data or statistical estimates. It outlines that diagnosis relies on elevated serum ferritin and transferrin saturation, genetic testing, and non-invasive magnetic resonance imaging (MRI) for tissue iron assessment. It notes that ongoing monitoring of iron indices and organ function is necessary to prevent severe outcomes, including myocardial dysfunction, liver cirrhosis, and hepatocellular carcinoma.
Why it matters
The paper synthesizes standard diagnostic and monitoring workflows across primary and transfusion-related iron overload conditions to guide clinical surveillance and prevent end-organ damage.
Limits
As a narrative review, it presents no original empirical data, sample sizes, or systematic search methodology. The abstract provides no specific numerical diagnostic cutoffs, monitoring intervals, or quantitative effect sizes.
Cited by
- supports Hemochromatosis is a genetic condition characterized by excessive iron accumulation in the body.